Sanovel Iiac San Ve Tic competitive analysis

Explore patent oppositions filed by Sanovel Iiac San Ve Tic against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jan 29, 2026
Patent NumberTitleApplicantOpposition Date
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTISDec 7, 2023
Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIMJun 13, 2023

Latest PTAB cases involving Sanovel Iiac San Ve Tic

Discover the latest PTAB cases involving Sanovel Iiac San Ve Tic, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Sanovel Iiac San Ve Tic with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 29, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SANOVEL IIAC SAN VE TIC2 - - -
BOEHRINGER INGELHEIM49179109
NOVARTIS6424 - 21